The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2017-07-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0043-109242PMID 28704857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database.

  2016cited by this paper
• The benefits and risks of DPP4‐inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial

  2016cited by this paper
• Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis

  2016cited by this paper
• The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis.

  2015cited by this paper
• Sulfonylureas and their use in clinical practice

  2015cited by this paper
• Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

  2015cited by this paper
• Glycaemic control, treatment satisfaction and quality of life in type 2 diabetes patients in Greece: The PANORAMA study Greek results.

  2015cited by this paper
• Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database

  2015cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2014cited by this paper
• Effects of sitagliptin beyond glycemic control: focus on quality of life

  2013cited by this paper
• Achievement of goals in U.S. Diabetes Care, 1999-2010.

  2013cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus.

  2011cited by this paper
• Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study

  2011cited by this paper
• Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific-Real-life effectiveness and care patterns of diabetes management: the RECAP-DM study.

  2010cited by this paper
• Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) Study

  2008cited by this paper
• Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• The economic and quality of life impact of hypoglycemia

  2005cited by this paper
• Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes

  2005cited by this paper
• Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.

  2004cited by this paper
• Health and Quality of Life Outcomes

  2004influential reference
• Hypoglycemia as a barrier to glycemic control.

  2004cited by this paper
• Improving Adherence and Reducing Medication Discrepancies in Patients with Diabetes

  2003cited by this paper
• Hypoglycemia in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Hypoglycemia is the limiting factor in the management of diabetes

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• EuroQol : a new facility for the measurement of health-related quality of life

  1990cited by this paper
• Fear of Hypoglycemia: Quantification, Validation, and Utilization

  1987cited by this paper
• Hypoglycemia: Causes, neurological manifestations, and outcome

  1985cited by this paper
• Severe Hypoglycemia During Maximized Insulin Treatment of Diabetes in a Randomized Clinical Trial

  1983cited by this paper
• Hypoglycaemia in Patients with Type 2 Diabetes Mellitus Treated with Sulfonylureas: a Systematic Review and Meta-analysis

  year unknowncited by this paper

• Assessment of patient-centered outcomes in young children with differences of sex development.

  2025cites this paper
• Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study).

  2025cites this paper
• Determinants of medication adherence in patients with diabetes, hypertension, and hyperlipidemia

  2025cites this paper
• Management of Enterprises in the Greek Economy

  2025cites this paper
• Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature

  2024influential citation
• Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression

  2024cites this paper
• A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates

  2022cites this paper
• Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece

  2022cites this paper
• Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Diyabet Merkezden Takipli Tip 2 Diabetes Mellitus Hastalarında Hipoglisemi Sıklığı ve Hipoglisemi Korkusu

  2022cites this paper
• Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis.

  2021cites this paper
• Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission.

  2021cites this paper
• Diabetes-related quality of life in six European countries measured with the DOQ-30

  2021cites this paper
• Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes.

  2021cites this paper
• Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece

  2021cites this paper
• Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study

  2020cites this paper
• Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

  2020cites this paper
• Sulfonylureas as treatment choice in Diabetes Mellitus : Where are we now?

  2019cites this paper
• Systematic Review or Meta-analysis Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review

  year unknowncites this paper